FBXL4-Related Mitochondrial DNA Depletion Syndrome 13 (MTDPS13): A Case Report With a Comprehensive Mutation Review
- PMID: 30804983
- PMCID: PMC6370620
- DOI: 10.3389/fgene.2019.00039
FBXL4-Related Mitochondrial DNA Depletion Syndrome 13 (MTDPS13): A Case Report With a Comprehensive Mutation Review
Abstract
Mitochondrial DNA depletion syndromes (MTDPS) are a group of rare genetic disorders caused by defects in multiple genes involved in mitochondrial DNA (mtDNA) maintenance. Among those, FBXL4 mutations result in the encephalomyopathic mtDNA depletion syndrome 13 (MTDPS13; OMIM #615471), which commonly presents as a combination of failure to thrive, neurodevelopmental delays, encephalopathy, hypotonia, and persistent lactic acidosis. We report here the case of a Lebanese infant presenting to us with profound neurodevelopmental delays, generalized hypotonia, facial dysmorphic features, and extreme emaciation. Whole-exome sequencing (WES) showed the girl as having MTDPS13 with an underlying FBXL4 missense mutation that has been previously reported only twice in unrelated individuals (c.1303C > T). Comprehensive literature search marked our patient as being the 94th case of MTDPS13 reported to date worldwide, and the first from Lebanon. We include at the end of this report a comprehensive mutation review table of all the pathological FBXL4 mutations reported in the literature, using it to highlight, for the first time, a possible founder effect of Arab origins to the disorder, being most prevalent in patients of Arab descent as shown in our mutation table. Finally, we provide a direct comparison of the disorder's clinical manifestations across two unrelated patients harboring the same disease-causing mutation as our patient, emphasizing the remarkable variability in genotype-to-phenotype correlation characteristic of the disease.
Keywords: FBXL4; genetic mutations; mitochondria; mitochondrial DNA (mtDNA); mitochondrial diseases; mitochondrial fusion; pediatric genetics; rare diseases.
Similar articles
-
A Mild Phenotype of Mitochondrial DNA Depletion Syndrome Type 13 with a Novel FBXL4 Variant.Mol Syndromol. 2021 Aug;12(5):294-299. doi: 10.1159/000515928. Epub 2021 Jul 19. Mol Syndromol. 2021. PMID: 34602956 Free PMC article.
-
The First Reported Case of a Child with Two Different Rare Metabolic Disorders: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency and Encephalomyopathic Mitochondrial DNA Depletion Syndrome 13.Glob Med Genet. 2023 Oct 10;10(4):278-281. doi: 10.1055/s-0043-1775979. eCollection 2023 Dec. Glob Med Genet. 2023. PMID: 37822418 Free PMC article.
-
A novel mutation in FBXL4 in a Norwegian child with encephalomyopathic mitochondrial DNA depletion syndrome 13.Eur J Med Genet. 2016 Jun;59(6-7):342-6. doi: 10.1016/j.ejmg.2016.05.005. Epub 2016 May 13. Eur J Med Genet. 2016. PMID: 27182039
-
FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome.2017 Apr 6. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2017 Apr 6. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 28383868 Free Books & Documents. Review.
-
Molecular and clinical spectra of FBXL4 deficiency.Hum Mutat. 2017 Dec;38(12):1649-1659. doi: 10.1002/humu.23341. Epub 2017 Oct 6. Hum Mutat. 2017. PMID: 28940506 Review.
Cited by
-
Dual-localized PPTC7 limits mitophagy through proximal and dynamic interactions with BNIP3 and NIX.Life Sci Alliance. 2024 Jul 11;7(9):e202402765. doi: 10.26508/lsa.202402765. Print 2024 Sep. Life Sci Alliance. 2024. PMID: 38991726 Free PMC article.
-
Metabolite Genome-Wide Association Study (mGWAS) and Gene-Metabolite Interaction Network Analysis Reveal Potential Biomarkers for Feed Efficiency in Pigs.Metabolites. 2020 May 15;10(5):201. doi: 10.3390/metabo10050201. Metabolites. 2020. PMID: 32429265 Free PMC article.
-
FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors.EMBO J. 2023 Jul 3;42(13):e112767. doi: 10.15252/embj.2022112767. Epub 2023 May 10. EMBO J. 2023. PMID: 37161784 Free PMC article.
-
Recent advances in mitochondrial diseases: From molecular insights to therapeutic perspectives.Saudi Pharm J. 2022 Aug;30(8):1065-1078. doi: 10.1016/j.jsps.2022.05.011. Epub 2022 May 28. Saudi Pharm J. 2022. PMID: 36164575 Free PMC article. Review.
-
Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.Genes (Basel). 2021 Feb 10;12(2):247. doi: 10.3390/genes12020247. Genes (Basel). 2021. PMID: 33578638 Free PMC article. Review.
References
-
- Almannai M., Dai H., El-Hattab A. W., Wong L. J. C. (2017). FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome, in GeneReviews ®, eds Pagon R. A., Adam M. P., Ardinger H. H. A, Wallace S. E., Amemiya A., Bean L. J. H., Bird T. D., Ledbetter N., Mefford H. C., Smith R. J. H., Stephens K. (Seattle, WA: University of Washington; ). Available online at: http://www.ncbi.nlm.nih.gov/books/NBK425540/ - PubMed
-
- Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J. W., et al. . (1996). SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box. Cell 86, 263–274. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources